A data-driven analysis of potency, purity, and manufacturing consistency across the peptide market.
As peptide products become more widely accessible, consistency in manufacturing and labeling becomes increasingly important. This report provides a reference framework for understanding how products perform relative to commonly applied quality benchmarks.
Key Findings:
- A significant portion of tested products fell outside a 90–110% potency range
- Upward bias in label claim was observed across multiple peptide categories
- Purity levels were generally high, but with a measurable tail below 98%
- Variability across suppliers indicates uneven manufacturing consistency
- Sterility and endotoxin testing identified variability in aseptic control
Why This Matters:
As peptide products become more widely accessible, consistency in manufacturing and labeling becomes increasingly important. This report provides a reference framework for evaluating how products perform relative to commonly applied quality benchmarks.
What’s Inside the Report:
- Potency distribution across major peptide categories
- Purity analysis relative to specification thresholds
- Process capability and variability trends
- Sterility and endotoxin observations
- Year-over-year comparison (2024 vs 2025)
About the Data:
This report is based on anonymized laboratory testing data collected during routine quality control activities. Results reflect observed variability within tested samples and are not intended to represent individual suppliers.
About Qualsera
Qualsera is an independent certification body focused on improving transparency and consistency in the peptide market through data-driven quality standards and verification.